|
Post by liane on May 21, 2021 10:54:16 GMT -5
LFD has a new hit piece on SA if anyone cares to read it. I personally will use it to line the litter box. On second thought, maybe not. It don't want my sweet innocent kittens having contact with this slime. Not one ounce of truth in the article if you want to save the effort.
|
|
|
Post by longliner on May 21, 2021 11:44:02 GMT -5
LFD has a new hit piece on SA if anyone cares to read it. I personally will use it to line the litter box. On second thought, maybe not. It don't want my sweet innocent kittens having contact with this slime. Not one ounce of truth in the article if you want to save the effort.
Perhaps he can take his seat with Shkrelli and AF. Apparently some manipulation was needed today......SEC...SEC....Hello!!
|
|
|
Post by obamayoumama on May 21, 2021 11:45:56 GMT -5
LFD has a new hit piece on SA if anyone cares to read it. I personally will use it to line the litter box. On second thought, maybe not. It don't want my sweet innocent kittens having contact with this slime. Not one ounce of truth in the article if you want to save the effort.
Perhaps he can take his seat with Shkrelli and AF. Apparently some manipulation was needed today......SEC...SEC....Hello!! One has to wonder if he is being paid to Bash. My guess is that he is being paid.
|
|
|
Post by centralcoastinvestor on May 21, 2021 12:33:51 GMT -5
It is just a trash article. In doesn’t even make sense in light of yesterdays Annual Meeting info.
|
|
|
Post by neil36 on May 21, 2021 13:41:08 GMT -5
The article embellishes the side-effects of clofazimine. Interestingly, in yesterday’s meeting, Dr. Hofman, the Chief Medical Officer addressed this directly (starting at 18:45 on the recording) about how the direct inhalation of clofazimine goes directly to the point of infection while avoiding the systemic side effects. He says that 120,000 people a year die of this and he referred to it as a substantial unmet need.
The headline and much of the article is very misleading in trying to convince the reader that MNKD is abandoning Technosphere, when in fact they are doubling down and tripling down at every opportunity, based upon successful trial results. The article really twists a couple comments about Tyvaso migration from nebulizer to DPI. Anyone who has been following the UTHR story knows that the conversion will be significant.
|
|
|
Post by hellodolly on May 21, 2021 14:09:55 GMT -5
FROM LFD's last piece, written in June 2020: It is my sincere hope and desire that by some means Afrezza can remain available for those patients who need options in treating their medical condition. The same applies for Tre-t. Any new drug that is FDA approved, patients needing options should have it available.
|
|
|
Post by longliner on May 21, 2021 14:31:33 GMT -5
Apparently there are some volume of puts that needed his attention...er manipulation today.
|
|
|
Post by mymann on May 21, 2021 14:43:49 GMT -5
There's going to be more scumbags coming to attack mnkd again. Adam F. must have trained his students how to be useless part of our society.
|
|
|
Post by lennymnkd on May 21, 2021 14:51:09 GMT -5
I was drained reading it ! Hope you guys are right ,
|
|
|
Post by mnkdfann on May 21, 2021 15:29:42 GMT -5
FROM LFD's last piece, written in June 2020: It is my sincere hope and desire that by some means Afrezza can remain available for those patients who need options in treating their medical condition. The same applies for Tre-t. Any new drug that is FDA approved, patients needing options should have it available. He usually (always?) includes a comment like that. From today's article: "It is my sincere wish that Afrezza remains available for those patients needing options for treating their diabetic condition. I hope that any drug addressing the debilitating PAH condition will be a successful drug—whether in DPI delivery format or delivered by a nebulizer."
|
|
|
Post by neil36 on May 21, 2021 17:10:54 GMT -5
He adds the insincere concern for patients because he has been heavily criticized as a hard-core basher for years, who is just trying to help out hedge fund buddies at the expense of patients with horrible diseases.
His thesis today is that Tyvaso DPI is losing confidence. He says this while hiding behind an anonymous screen name. Meanwhile, Martine just wrote the FDA a check for $105 million for a Priority Review. That just SCREAMS high confidence. Money talks, BS walks.
|
|
|
Post by cretin11 on May 21, 2021 17:39:33 GMT -5
As someone who used to leave comments under LFD’s articles criticizing his arguments for why Afrezza would not be the blockbuster we all predicted, it is painful to look back to see who got the better end of those predictions.
I don’t know if LFD was being paid to write those articles. Probably not, but it doesn’t matter much, and had nothing to do with the failure of the Afrezza product launch(es). Let’s just hope he’s wrong about Tyvaso.
|
|
|
Post by lennymnkd on May 21, 2021 17:53:27 GMT -5
The article embellishes the side-effects of clofazimine. Interestingly, in yesterday’s meeting, Dr. Hofman, the Chief Medical Officer addressed this directly (starting at 18:45 on the recording) about how the direct inhalation of clofazimine goes directly to the point of infection while avoiding the systemic side effects. He says that 120,000 people a year die of this and he referred to it as a substantial unmet need. FROM NEIL36 ..keeping me sane...
|
|
|
Post by mnkdfann on May 21, 2021 19:00:12 GMT -5
The article embellishes the side-effects of clofazimine. Interestingly, in yesterday’s meeting, Dr. Hofman, the Chief Medical Officer addressed this directly (starting at 18:45 on the recording) about how the direct inhalation of clofazimine goes directly to the point of infection while avoiding the systemic side effects. He says that 120,000 people a year die of this and he referred to it as a substantial unmet need. FROM NEIL36 ..keeping me sane... What Hofman said, as you noted, was that direct inhalation would reduce " systemic side effects of taking a drug orally" which I believe is not the same thing as what LFD is talking about. (I think) Systemic side effects of taking a (any) drug orally are not the same as specific side-effects tied to taking Clofazimine in particular. That doesn't mean LFD is correct, but I don't think Hofman's statement addressed what LFD said.
|
|
|
Post by lennymnkd on May 22, 2021 5:03:31 GMT -5
Does first pass hepatic metabolism ( TECHNOSPHERE) account for anything
|
|